Genital Psoriasis: Results of New Study : vimarsana.com

Genital Psoriasis: Results of New Study

Amgen today announced positive top-line results from the DISCREET trial, a Phase 3, multicenter, randomized, placebo-controlled, double-blind study to assess the efficacy of Otezla® (apremilast) in adults with moderate to severe genital psoriasis and moderate to severe plaque psoriasis. - Click here if this is your press release! - eTurboNews | Trends | Travel News

Related Keywords

, Global Assessment , Genital Psoriasis Itch Numerical Rating Scale , Genital Psoriasis Symptoms , Dermatology Life Quality Index ,

© 2025 Vimarsana